News & Analysis on Clinical Trial Services & Contract Research And Development
Private pharmaceutical firm Tolmar has sold off its pharmaceutical manufacturing plant in a move to fund the purchase of the US assets of biopharmaceutical QLT. The plant, sold for $13.6m (€10.5m), will be leased back to Tolmar under a long-term...
A security technology that had been strictly limited to use by governmental organisations is now available commercially, with several major pharmaceutical manufacturers keen to snap up the device and protect their supply chain. The product is set...
MDS pharma has ceased operations at its bioanalytical services facility in Blainville, Quebec in a bid to boost profitability after an ongoing investigation of the site by the US Food and Drug Administration (FDA).
US Food and Drug Administration (FDA) has until April 2007 to reply to a Citizen's Petition (CP) filed by Orchid Chemicals in response to accusations of 'evergreening' related to Wyeth's re-formulated Zosyn (piperacillin/tazobactam), an injectable...
US outsourcing company Covance has announced it is to open a central laboratory in China in order to meet the growing demand for clinical trials conducted in the region and has expanded its capabilities in Texas.
US Democrats spearheaded by Henry Waxman intend to re-table a stalled piece of legislation that would allow US Food and Drug Administration (FDA) approval of generic biodrugs, which they claim would result in cost savings for patients and healthcare...
Wyeth Pharmaceuticals is expanding its research into delivery systems for haemophilia drugs through a collaboration deal with MediVas.
Outsourcing-Pharma.com compiles the news that featured in the clinical contract research world last week.
US-based start-up company Medipacs is developing a miniaturised digital pump, no bigger than a quarter, which could become the first patch-like product to help diabetics manage their insulin therapy.